openPR Logo
Press release

Anti-Hypertensive Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-2026

10-14-2020 08:48 AM CET | Health & Medicine

Press release from: ORION MARKET RESEARCH

Anti-Hypertensive Drugs Market Trends, Size, Competitive

The global anti-hypertensive drugs market is anticipated to grow at a CAGR of over 4% during the forecast period. The anti-hypertensive drugs are used to restrict any complications of high blood pressure including myocardial infarction, stroke, and many more. In addition to this, anti-hypertensive drugs have their primary action on systemic vascular resistance and it also reduces systemic vascular resistance with long-term use. Moreover, hypertension is directly associated with increased cardiovascular risk, and reducing blood pressure and the use of the anti-hypertensive drug is recommended which significantly decreases such risks. Hence, factors such as increasing cases of diabetes, hypertension, cardiovascular diseases associated with high blood pressure will directly impact the growth of the global anti-hypertensive market during the forecast period.

Request a Free Sample of our Anti-Hypertensive Drugs Market: https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market

However, the high cost associated with anti-hypertensive drugs will turn out to be a major restraint for the growth of the anti-hypertensive market, as it has to be given to the patient for a longer period. Additionally, the low awareness and less diagnosis rate in the developing countries will also hamper the growth of the anti-hypertensive drugs market during the forecast period. Moreover, the side effects of anti-hypertensive drugs such as calcium channel blockers used during pregnancy include tachycardia, palpitations, peripheral edema, headaches, and facial flushing, which will lower the adoption of these drugs. Hence, the low adoption rate of anti-hypertensive drugs during pregnancy will majorly restrict the growth of the anti-hypertensive drug market during the forecast period.

A full Report of Anti-Hypertensive Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market
Anti-Hypertensive Drugs Market Segmentation

By Drug Class

• Thiazide Diuretics
• Calcium Channel Blockers
• ACE Inhibitors
• Angiotensin II Receptor Antagonists (ARBS)
• Beta Blockers
• Others

Regional Analysis

• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Co., Ltd.
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Merck KGaA
• Noden Pharma DAC
• Novartis International AG
• Pfizer Inc.
• Ranbaxy Laboratories Ltd.
• Renata Ltd.
• Sanofi S.A.
• Sun Pharmaceuticals LLC
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.
• Unichem Laboratories Ltd.
• United Therapeutics Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anti-hypertensive-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Hypertensive Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-2026 here

News-ID: 2158557 • Views:

More Releases from ORION MARKET RESEARCH

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT
Supply Chain Security Market Set to Witness Significant Growth by 2033 | Testo SE & Co. KGaA, Orbcomm Inc., Sensitech Inc
Supply Chain Security Market Set to Witness Significant Growth by 2033 | Testo S …
The global Supply Chain Security Market was valued at USD 2.6 billion in 2024 and is projected to reach USD 6.2 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.64% from 2025 to 2033. Supply Chain Security Market Overview The Supply Chain Security Market is experiencing significant growth due to increasing concerns over cyber threats, data breaches, and the need for real-time tracking and monitoring of shipments.
Subscription Billing Management Market Set to Witness Significant Growth by 2034 | Recurly, Zoho Corporation, Zuora, Chargebee, and 2Checkout
Subscription Billing Management Market Set to Witness Significant Growth by 2034 …
The global Subscription Billing Management Market was valued at USD 7.90 billion in 2024 and is projected to reach USD 20.75 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.33% from 2025 to 2033. Subscription Billing Management Market Overview The Subscription Billing Management Market is experiencing significant growth due to the increasing adoption of subscription-based business models across various industries, including IT, telecommunications, BFSI, retail, healthcare, and
Distributed Fiber Optic Sensor Market Set to Witness Significant Growth by 2033 | OFS Fitel, LLC, Bandweaver, Omnisens SA, AP Sensing GmbH, and DarkPulse Inc
Distributed Fiber Optic Sensor Market Set to Witness Significant Growth by 2033 …
The global Distributed Fiber Optic Sensor (DFOS) market was valued at approximately USD 1,415.6 million in 2024 and is projected to reach USD 3,650.6 million by 2033, growing at a compound annual growth rate (CAGR) of 11.1% from 2025 to 2033. Distributed Fiber Optic Sensor Market Overview The Distributed Fiber Optic Sensor (DFOS) market is experiencing significant growth due to the increasing demand for real-time monitoring and structural health assessment across

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase